ClinicalTrials.Veeva

Menu

Does Echocardiographically Guided Ventriculo-Ventricular Optimization Yield a Sustained Improvement in Echocardiographic Parameters in Cardiac Resynchronization Therapy Patients? (DEVISE CRT) (Devise-CRT)

Duke University logo

Duke University

Status

Completed

Conditions

Cardiomyopathy
Heart Failure

Treatments

Other: "Simultaneous Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)
Other: "Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00737490
Pro00007865
7314 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to determine whether using an echocardiogram (a painless test where ultrasound is used to see your heart) while using mild electrical stimulation from your own CRT-D device to stimulate the ventricles (the lower chambers of the heart) to squeeze one slightly earlier than the other will show a sustained increase your heart's productivity (Cardiac Output (CO)), following implantation of a Cardiac Resynchronization Device (CRT-D). We believe that squeezing some parts of the heart earlier than others may make the heart a stronger pump.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. LVEF </= 35% as assessed by echocardiography.
  2. New York Heart Association Functional Class III or IV CHF despite contemporary medical therapy for CHF.
  3. QRS duration of >/= 120 ms.
  4. Ability to provide written, informed consent.
  5. Age > 18 years.
  6. Successful implant of a biventricular/ICD pacemaker device.

Exclusion criteria

  1. Documented Chronic Atrial Fibrillation
  2. Life expectancy less that 6 months due to non-cardiac causes
  3. Inability to place a coronary sinus left ventricular pacing lead
  4. Pregnancy
  5. Scheduled cardiac surgery within the next 6 months
  6. Prosthetic Tricuspid Valve

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

1
Active Comparator group
Description:
Echocardiographically guided optimized device programming: specifically sequential BiV pacing. "Sequential Arm"
Treatment:
Other: "Sequential Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)
2
Active Comparator group
Description:
Simultaneous BiV pacing. "Simultaneous Arm"
Treatment:
Other: "Simultaneous Arm" (Promote , model # 2207-36 or Atlas HF , model # V-343)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems